BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-21 Cr | ₹-25 Cr | ₹-24 Cr | ₹-21 Cr | ₹-6.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of BLISS GVS PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-21 Cr |
Mar2023 | ₹-25 Cr |
Mar2022 | ₹-24 Cr |
Mar2021 | ₹-21 Cr |
Mar2020 | ₹-6.30 Cr |
How is Cash Flow from Financing Activities of BLISS GVS PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-21 Cr | Negative | |
Mar2023 | ₹-25 Cr | Negative | |
Mar2022 | ₹-24 Cr | Negative | |
Mar2021 | ₹-21 Cr | Negative | |
Mar2020 | ₹-6.30 Cr | - |
Compare Cash Flow from Financing Activities of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,254.3 Cr | -5.8% | -1.7% | 5.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,126.0 Cr | 1.4% | 4.1% | 18.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,568.0 Cr | -2.1% | 4.2% | 59.1% | Stock Analytics | |
CIPLA | ₹125,156.0 Cr | -0.1% | 5% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,176.0 Cr | -0.3% | 3% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,716.1 Cr | -1.5% | 1.7% | -5.4% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | -5.8% |
-1.7% |
5.1% |
SENSEX | 0.2% |
2.9% |
8.7% |
You may also like the below Video Courses